NEW YORK, NY (Aug. 10) -- Only half of pregnant women worldwide who need a treatment developed over 50 years ago to prevent Rh disease--an often-fatal condition in fetuses and newborns that is now ...
In March, the U.S. FDA reported a major shortage of Rhogam, the anti-D immune globulin most widely used to prevent Rh factor incompatibility in pregnancy. Without treatment, second and subsequent ...
Pregnancy comes with several routine medical tests, and one of the most important is determining the blood group and Rhesus (Rh) factor of both parents. Although often overlooked, knowing a mother’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results